Premenstrual asthma

Emphasis on drug therapy options

Amy M. Redmond, Alan W. James, Shambria Haynie Nolan, Timothy Self

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Premenstrual asthma is quite common, affecting up to 40% of women. Some studies suggest exacerbations of asthma requiring emergency department visits or hospitalizations are more common in the perimenstrual phase. Several drug treatment modalities for premenstrual asthma have been evaluated. Drug therapies that may be beneficial include leukotriene receptor antagonists, long acting inhaled beta2 agonists, progesterone, estradiol, and gonadotropin-releasing hormone (GnRH) analogs. Further double-blind, randomized, placebo-controlled studies are required before the optimal drug therapy for premenstrual asthma is established.

Original languageEnglish (US)
Pages (from-to)687-693
Number of pages7
JournalJournal of Asthma
Volume41
Issue number7
DOIs
StatePublished - Dec 6 2004

Fingerprint

Asthma
Drug Therapy
Leukotriene Antagonists
Gonadotropin-Releasing Hormone
Progesterone
Hospital Emergency Service
Estradiol
Hospitalization
Placebos
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Redmond, A. M., James, A. W., Nolan, S. H., & Self, T. (2004). Premenstrual asthma: Emphasis on drug therapy options. Journal of Asthma, 41(7), 687-693. https://doi.org/10.1081/JAS-200027986

Premenstrual asthma : Emphasis on drug therapy options. / Redmond, Amy M.; James, Alan W.; Nolan, Shambria Haynie; Self, Timothy.

In: Journal of Asthma, Vol. 41, No. 7, 06.12.2004, p. 687-693.

Research output: Contribution to journalReview article

Redmond, AM, James, AW, Nolan, SH & Self, T 2004, 'Premenstrual asthma: Emphasis on drug therapy options', Journal of Asthma, vol. 41, no. 7, pp. 687-693. https://doi.org/10.1081/JAS-200027986
Redmond, Amy M. ; James, Alan W. ; Nolan, Shambria Haynie ; Self, Timothy. / Premenstrual asthma : Emphasis on drug therapy options. In: Journal of Asthma. 2004 ; Vol. 41, No. 7. pp. 687-693.
@article{06c545291bef40bc953d1d255707fe54,
title = "Premenstrual asthma: Emphasis on drug therapy options",
abstract = "Premenstrual asthma is quite common, affecting up to 40{\%} of women. Some studies suggest exacerbations of asthma requiring emergency department visits or hospitalizations are more common in the perimenstrual phase. Several drug treatment modalities for premenstrual asthma have been evaluated. Drug therapies that may be beneficial include leukotriene receptor antagonists, long acting inhaled beta2 agonists, progesterone, estradiol, and gonadotropin-releasing hormone (GnRH) analogs. Further double-blind, randomized, placebo-controlled studies are required before the optimal drug therapy for premenstrual asthma is established.",
author = "Redmond, {Amy M.} and James, {Alan W.} and Nolan, {Shambria Haynie} and Timothy Self",
year = "2004",
month = "12",
day = "6",
doi = "10.1081/JAS-200027986",
language = "English (US)",
volume = "41",
pages = "687--693",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Premenstrual asthma

T2 - Emphasis on drug therapy options

AU - Redmond, Amy M.

AU - James, Alan W.

AU - Nolan, Shambria Haynie

AU - Self, Timothy

PY - 2004/12/6

Y1 - 2004/12/6

N2 - Premenstrual asthma is quite common, affecting up to 40% of women. Some studies suggest exacerbations of asthma requiring emergency department visits or hospitalizations are more common in the perimenstrual phase. Several drug treatment modalities for premenstrual asthma have been evaluated. Drug therapies that may be beneficial include leukotriene receptor antagonists, long acting inhaled beta2 agonists, progesterone, estradiol, and gonadotropin-releasing hormone (GnRH) analogs. Further double-blind, randomized, placebo-controlled studies are required before the optimal drug therapy for premenstrual asthma is established.

AB - Premenstrual asthma is quite common, affecting up to 40% of women. Some studies suggest exacerbations of asthma requiring emergency department visits or hospitalizations are more common in the perimenstrual phase. Several drug treatment modalities for premenstrual asthma have been evaluated. Drug therapies that may be beneficial include leukotriene receptor antagonists, long acting inhaled beta2 agonists, progesterone, estradiol, and gonadotropin-releasing hormone (GnRH) analogs. Further double-blind, randomized, placebo-controlled studies are required before the optimal drug therapy for premenstrual asthma is established.

UR - http://www.scopus.com/inward/record.url?scp=9144230359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144230359&partnerID=8YFLogxK

U2 - 10.1081/JAS-200027986

DO - 10.1081/JAS-200027986

M3 - Review article

VL - 41

SP - 687

EP - 693

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 7

ER -